Clinical Trial Update: Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating subcutaneous hydrocortisone in children with congenital adrenal hyperplasia. The study is completed and results were posted on 2025-06-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Hydrocortisone (subcutaneous) (hydrocortisone)

Snippet

Sponsor: University of Minnesota | Conditions: Congenital Adrenal Hyperplasia, Hyperplasia | Phase 1 | Status: COMPLETED | Results posted: 2025-06-25